Cardiovascular Protection Associated With Cilostazol, Colchicine, and Target of Rapamycin Inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000001276
Abstract: Abstract: An alteration in extracellular matrix (ECM) production by vascular smooth muscle cells is a crucial event in the pathogenesis of vascular diseases such as aging-related, atherosclerosis and allograft vasculopathy. The human target of rapamycin… read more here.
Keywords: cardiovascular protection; target rapamycin; disease; cilostazol colchicine ... See more keywords